Search research articles
Contact Us
Filters
Showing results (41-50 of 98) with videos related to
Page
of 10
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 27, 2016
Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental?
Michael J Zelefsky, Marisa A Kollmeier, Elan Gorshein, et al.
Journal of Tissue Engineering and Regenerative Medicine
|
July 12, 2011
Osteoblast growth and bone-healing response to three-dimensional poly(ε-caprolactone fumarate) scaffolds
Jinku Kim, Aditi Sharma, Brett Runge, et al.
The Laryngoscope
|
July 21, 2016
Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma
Jin-Gao Li, Praveen Venigalla, Jonathan E Leeman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2025
Precision in Practice: A Critical Overview of Recent Advances in Nasopharyngeal Cancer Management
Shao Hui Huang, Wai Tong Ng, Richard L Bakst, et al.
Journal of Foot and Ankle Research
|
March 3, 2026
Establishing Normative Values for the Supination Resistance Test: An International Cross-Sectional Study
Gabriel Moisan, Pier-Luc Isabelle, Álvaro Gómez Carrión, et al.
The Journal of Urology
|
July 14, 2015
Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer
Zachary S Zumsteg, Daniel E Spratt, Paul B Romesser, et al.
Head & Neck
|
May 17, 2020
Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma
Nipun Verma, Suchit Patel, Virginia Osborn, et al.
Brachytherapy
|
May 16, 2026
Early outcomes of partial gland (focal) salvage brachytherapy for radiorecurrent prostate cancer
Aneesh Dhar, Victoria Brennan, Sankalp Pandya, et al.
Brachytherapy
|
June 20, 2022
Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost
Marisa A Kollmeier, Daniel Gorovets, Jessica Flynn, et al.
Brachytherapy
|
December 16, 2017
Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103
Amandeep S Taggar, Tomer Charas, Gil'ad N Cohen, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 98) with videos related to
Sort By:
Page
of 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 27, 2016
Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental?
Michael J Zelefsky, Marisa A Kollmeier, Elan Gorshein, et al.
Journal of Tissue Engineering and Regenerative Medicine
|
July 12, 2011
Osteoblast growth and bone-healing response to three-dimensional poly(ε-caprolactone fumarate) scaffolds
Jinku Kim, Aditi Sharma, Brett Runge, et al.
The Laryngoscope
|
July 21, 2016
Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma
Jin-Gao Li, Praveen Venigalla, Jonathan E Leeman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 2025
Precision in Practice: A Critical Overview of Recent Advances in Nasopharyngeal Cancer Management
Shao Hui Huang, Wai Tong Ng, Richard L Bakst, et al.
Journal of Foot and Ankle Research
|
March 3, 2026
Establishing Normative Values for the Supination Resistance Test: An International Cross-Sectional Study
Gabriel Moisan, Pier-Luc Isabelle, Álvaro Gómez Carrión, et al.
The Journal of Urology
|
July 14, 2015
Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer
Zachary S Zumsteg, Daniel E Spratt, Paul B Romesser, et al.
Head & Neck
|
May 17, 2020
Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma
Nipun Verma, Suchit Patel, Virginia Osborn, et al.
Brachytherapy
|
May 16, 2026
Early outcomes of partial gland (focal) salvage brachytherapy for radiorecurrent prostate cancer
Aneesh Dhar, Victoria Brennan, Sankalp Pandya, et al.
Brachytherapy
|
June 20, 2022
Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost
Marisa A Kollmeier, Daniel Gorovets, Jessica Flynn, et al.
Brachytherapy
|
December 16, 2017
Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103
Amandeep S Taggar, Tomer Charas, Gil'ad N Cohen, et al.
Page
of 10